A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy
Understand AAV workflows through detailed lab and bioinformatic processes!
Adeno-associated virus (AAV) vectors have become an ideal vehicle for in vivo gene therapy due to their efficiency and safety in humans. However, there are many challenges to overcome during the AAV production process for rapid drug development.
在Andrea O'Hara博士的领导下,该研讨会将通过涵盖AAV实验室和生物信息学分析过程来帮助您了解AAV工作流程。从上游开发开始,我们回顾了基因合成,AAV质粒制备以及可用于AAV生产和验证的测序选项。然后,我们讨论对最终包装产品的下游分析,以确认纯度,克隆性和忠诚度。
Presenters and Roundtable Experts
- Andrea O’Hara, Ph.D., Strategic Technical Specialist, Azenta
- Elizabeth Louie, Ph.D., Supervisor, Technical Applications, Azenta
- Xiangying (Candy) Mao, Ph.D., Team Lead, Bioinformatics, Azenta
- Ming Yang, Ph.D., Business Process Manager, Azenta
- Liz Tseng, Ph.D., Associate Director, PacBio
Learning Objectives
- How to optimize AAV plasmid preparation
- Best practices to address unstable sequencing
- 存储和索引AAV产品的解决方案
- Selection of purity and fidelity assays
- 用于解释复杂数据的生物信息学工具
- GLP sequencing confirmation solutions
To learn more, fill out the form to watch the on-demand workshop today!